These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10195355)

  • 1. Regulation and modulation of eosinophil effector functions.
    Elsner J; Kapp A
    Allergy; 1999 Jan; 54(1):15-26. PubMed ID: 10195355
    [No Abstract]   [Full Text] [Related]  

  • 2. Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity.
    Gaga M; Frew AJ; Varney VA; Kay AB
    J Immunol; 1991 Aug; 147(3):816-22. PubMed ID: 1830598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of transendothelial migration on eosinophil function.
    Yamamoto H; Sedgwick JB; Vrtis RF; Busse WW
    Am J Respir Cell Mol Biol; 2000 Sep; 23(3):379-88. PubMed ID: 10970830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of specific T lymphocytes in systemic abnormal delayed type hypersensitivity to Candida albicans.
    Cozon GJ; Brunet JL; Peyramond D
    Inflamm Res; 2000 Apr; 49 Suppl 1():S39-40. PubMed ID: 10864413
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergistic effects of interleukin-4 or interleukin-13 and tumor necrosis factor-alpha on eosinophil activation in vitro.
    Luttmann W; Matthiesen T; Matthys H; Virchow JC
    Am J Respir Cell Mol Biol; 1999 Mar; 20(3):474-80. PubMed ID: 10030846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative and functional analysis of CD69(+) NKG2D(+) T regulatory cells in healthy subjects.
    Vitales-Noyola M; Doníz-Padilla L; Álvarez-Quiroga C; Monsiváis-Urenda A; Portillo-Salazar H; González-Amaro R
    Hum Immunol; 2015 Jul; 76(7):511-8. PubMed ID: 26079506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion.
    Herman AE; Freeman GJ; Mathis D; Benoist C
    J Exp Med; 2004 Jun; 199(11):1479-89. PubMed ID: 15184501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gedunin, a natural tetranortriterpenoid, modulates T lymphocyte responses and ameliorates allergic inflammation.
    Ferraris FK; Moret KH; Figueiredo AB; Penido C; Henriques Md
    Int Immunopharmacol; 2012 Sep; 14(1):82-93. PubMed ID: 22709475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased CD69 Expression on Peripheral Eosinophils from Patients with Food Protein-Induced Enterocolitis Syndrome.
    Wada T; Matsuda Y; Toma T; Koizumi E; Okamoto H; Yachie A
    Int Arch Allergy Immunol; 2016; 170(3):201-5. PubMed ID: 27595267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines.
    Hartnell A; Robinson DS; Kay AB; Wardlaw AJ
    Immunology; 1993 Oct; 80(2):281-6. PubMed ID: 8262555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of activation antigen CD69 on eosinophils].
    Morii T; Nishikawa K; Ako H; Narita N
    Nihon Rinsho; 1993 Mar; 51(3):588-92. PubMed ID: 8492431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
    Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of activated eosinophils in infants with severe atopic dermatitis.
    Toma T; Mizuno K; Okamoto H; Kanegane C; Ohta K; Ikawa Y; Miura M; Kuroda M; Niida Y; Koizumi S; Yachie A
    Pediatr Int; 2005 Feb; 47(1):32-8. PubMed ID: 15693863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthetic PPARgamma agonist troglitazone inhibits IL-5-induced CD69 upregulation and eosinophil-derived neurotoxin release from eosinophils.
    Matsuwaki Y; Ueki S; Adachi T; Oyamada H; Kamada Y; Yamaguchi K; Kanda A; Hamada K; Kayaba H; Chihara J
    Pharmacology; 2005 Jul; 74(4):169-73. PubMed ID: 15818060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro expansion of CD4+CD25highFOXP3+CD127low/- regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans.
    Hougardy JM; Verscheure V; Locht C; Mascart F
    Microbes Infect; 2007 Sep; 9(11):1325-32. PubMed ID: 17890131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of Churg-Strauss syndrome: flow cytometric analysis of the surface activation markers of peripheral eosinophils.
    Nakahigashi K; Otsuka A; Miyachi Y; Kabashima K; Tanioka M
    Acta Derm Venereol; 2013 Jan; 93(1):100-1. PubMed ID: 22688790
    [No Abstract]   [Full Text] [Related]  

  • 17. Absence of CD69 expression on peripheral eosinophils in episodic angioedema and eosinophilia.
    Kawano M; Muramoto H; Tsunoda S; Koni I; Mabuchi H; Yachie A; Miyawaki T
    Am J Hematol; 1996 Sep; 53(1):43-5. PubMed ID: 8813097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies.
    Elsner J; Oppermann M; Kapp A
    Eur J Immunol; 1996 Jul; 26(7):1560-4. PubMed ID: 8766561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxic epidermal necrolysis in the absence of circulating T cells: a possible role for resident memory T cells.
    Iriki H; Adachi T; Mori M; Tanese K; Funakoshi T; Karigane D; Shimizu T; Okamoto S; Nagao K
    J Am Acad Dermatol; 2014 Nov; 71(5):e214-6. PubMed ID: 25437999
    [No Abstract]   [Full Text] [Related]  

  • 20. Does IgE bind to and activate eosinophils from patients with allergy?
    Kita H; Kaneko M; Bartemes KR; Weiler DA; Schimming AW; Reed CE; Gleich GJ
    J Immunol; 1999 Jun; 162(11):6901-11. PubMed ID: 10352312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.